Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000707721 | SCV000836830 | pathogenic | Fetal akinesia deformation sequence 1; Congenital myasthenic syndrome 10 | 2022-06-04 | criteria provided, single submitter | clinical testing | For these reasons, this variant has been classified as Pathogenic. This variant disrupts a region of the DOK7 protein in which other variant(s) (p.Ala378Serfs*30) have been determined to be pathogenic (PMID: 16917026, 18165682, 18626973, 22661499, 25237101). This suggests that this is a clinically significant region of the protein, and that variants that disrupt it are likely to be disease-causing. This variant has not been reported in the literature in individuals affected with DOK7-related conditions. This variant is not present in population databases (gnomAD no frequency). This sequence change creates a premature translational stop signal (p.His250Leufs*12) in the DOK7 gene. While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 255 amino acid(s) of the DOK7 protein. |
Baylor Genetics | RCV003465641 | SCV004194020 | likely pathogenic | Fetal akinesia deformation sequence 3 | 2023-10-05 | criteria provided, single submitter | clinical testing |